The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomaterials, which, therefore, are considered as a significant next-generation therapeutic option. Thus, the development of novel antiviral nanoagents will certainly help address several future challenges and knowledge gaps.

中文翻译：

---

抗病毒纳米剂：需要更多的关注和努力吗？

最近的 COVID-19 爆发使研究人员越来越多地参与寻找有效的抗病毒药物和治疗方案。现有抗病毒药物的窄谱和低生物利用度等缺点可以通过使用工程纳米材料来克服，因此被认为是重要的下一代治疗选择。因此，新型抗病毒纳米剂的开发无疑将有助于解决未来的几个挑战和知识差距。